US Stock MarketDetailed Quotes

RPHM Reneo Pharmaceuticals

Watchlist

1.460
-0.040-2.67%

Close Jul 10 16:00 ET

1.460
0.0000.00%

Post 16:00 ET

48.79MMarket Cap-672P/E (TTM)

Reneo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-11.68%82.84M

1.77%102.96M

8.21%125.61M

12.48%142.68M

-32.36%93.79M

-31.49%101.17M

-26.41%116.08M

-24.19%126.85M

-Cash and cash equivalents

-32.97%20.38M

38.67%27.63M

-81.11%11.74M

-92.32%9.08M

-74.90%30.4M

-84.01%19.93M

-50.85%62.13M

-15.75%118.26M

-Short-term investments

-1.47%62.46M

-7.28%75.33M

111.09%113.88M

1,455.61%133.6M

260.84%63.39M

253.09%81.25M

72.22%53.95M

-68.15%8.59M

Other current assets

-66.20%1.09M

-29.36%3.66M

-35.79%3.16M

-29.39%3.64M

-20.28%3.23M

-14.58%5.18M

-0.26%4.92M

35.41%5.16M

Total current assets

-13.49%83.93M

0.25%106.62M

6.42%128.77M

10.84%146.32M

-32.02%97.02M

-30.82%106.35M

-25.62%121M

-22.86%132.01M

Non current assets

Net PPE

-63.37%648K

-57.99%733K

7.57%1.54M

7.97%1.64M

9.26%1.77M

723.11%1.75M

613.50%1.43M

1,687.06%1.52M

-Gross PPE

-63.37%648K

-53.82%853K

7.57%1.54M

7.97%1.64M

9.26%1.77M

435.36%1.85M

351.58%1.43M

707.98%1.52M

-Accumulated depreciation

----

-17.65%-120K

----

23.31%-102K

----

Other non current assets

-20.99%64K

-3.57%81K

2.53%81K

1.28%79K

3.85%81K

7.69%84K

1.28%79K

0.00%78K

Total non current assets

-61.51%712K

-55.49%814K

7.30%1.62M

7.64%1.72M

9.02%1.85M

530.69%1.83M

441.73%1.51M

879.75%1.6M

Total assets

-14.39%84.64M

-0.69%107.44M

6.44%130.39M

10.80%148.04M

-31.54%98.87M

-29.76%108.18M

-24.82%122.5M

-22.01%133.61M

Liabilities

Current liabilities

Payables

-62.49%676K

360.49%8.72M

12.97%2.47M

17.18%1.83M

15.07%1.8M

-6.38%1.89M

72.23%2.19M

259.45%1.56M

-accounts payable

-62.49%676K

360.49%8.72M

12.97%2.47M

17.18%1.83M

15.07%1.8M

-6.38%1.89M

72.23%2.19M

259.45%1.56M

Current accrued expenses

-90.30%637K

28.88%5.18M

51.95%6.94M

97.58%9.07M

40.63%6.57M

27.50%4.02M

22.82%4.56M

118.73%4.59M

Current debt and capital lease obligation

-8.82%331K

-18.07%331K

-20.73%325K

-22.06%318K

-20.57%363K

--404K

--410K

--408K

-Current capital lease obligation

-8.82%331K

-18.07%331K

-20.73%325K

-22.06%318K

-20.57%363K

--404K

--410K

--408K

Current liabilities

-73.15%2.81M

155.15%18.18M

43.52%13.56M

64.82%13.74M

32.50%10.48M

14.87%7.12M

48.75%9.45M

149.85%8.34M

Non current liabilities

Long term debt and capital lease obligation

-41.16%576K

-39.38%642K

-13.89%812K

-15.46%897K

-13.13%979K

--1.06M

--943K

--1.06M

-Long term capital lease obligation

-41.16%576K

-39.38%642K

-13.89%812K

-15.46%897K

-13.13%979K

--1.06M

--943K

--1.06M

Employee benefits

-97.84%7K

-75.86%7K

1,519.70%1.07M

1,492.73%876K

468.42%324K

-93.47%29K

-76.76%66K

-84.85%55K

Total non current liabilities

-55.26%583K

-40.35%649K

86.42%1.88M

58.87%1.77M

10.05%1.3M

78.07%1.09M

164.14%1.01M

167.63%1.12M

Total liabilities

-71.17%3.4M

129.25%18.83M

47.66%15.44M

64.12%15.51M

29.58%11.78M

20.53%8.21M

55.29%10.46M

151.83%9.45M

Shareholders'equity

Share capital

0.00%3K

-common stock

0.00%3K

Retained earnings

-49.48%-226.9M

-59.84%-218.47M

-54.79%-190.52M

-55.64%-171.32M

-55.26%-151.79M

-61.32%-136.68M

-66.06%-123.08M

-79.32%-110.08M

Paid-in capital

29.01%308.15M

29.73%307.07M

29.91%305.48M

29.83%303.88M

2.51%238.86M

2.07%236.69M

2.10%235.15M

2.24%234.06M

Gains losses not affecting retained earnings

-200.00%-12K

118.60%8K

19.23%-21K

-118.45%-31K

-81.25%12K

-226.47%-43K

-252.94%-26K

3,260.00%168K

Total stockholders'equity

-6.71%81.24M

-11.36%88.61M

2.59%114.94M

6.74%132.53M

-35.64%87.08M

-32.09%99.97M

-28.27%112.05M

-25.90%124.16M

Total equity

-6.71%81.24M

-11.36%88.61M

2.59%114.94M

6.74%132.53M

-35.64%87.08M

-32.09%99.97M

-28.27%112.05M

-25.90%124.16M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-11.68%82.84M	1.77%102.96M	1.77%102.96M	8.21%125.61M	12.48%142.68M	-32.36%93.79M	-31.49%101.17M	-31.49%101.17M	-26.41%116.08M	-24.19%126.85M
-Cash and cash equivalents	-32.97%20.38M	38.67%27.63M	38.67%27.63M	-81.11%11.74M	-92.32%9.08M	-74.90%30.4M	-84.01%19.93M	-84.01%19.93M	-50.85%62.13M	-15.75%118.26M
-Short-term investments	-1.47%62.46M	-7.28%75.33M	-7.28%75.33M	111.09%113.88M	1,455.61%133.6M	260.84%63.39M	253.09%81.25M	253.09%81.25M	72.22%53.95M	-68.15%8.59M
Other current assets	-66.20%1.09M	-29.36%3.66M	-29.36%3.66M	-35.79%3.16M	-29.39%3.64M	-20.28%3.23M	-14.58%5.18M	-14.58%5.18M	-0.26%4.92M	35.41%5.16M
Total current assets	-13.49%83.93M	0.25%106.62M	0.25%106.62M	6.42%128.77M	10.84%146.32M	-32.02%97.02M	-30.82%106.35M	-30.82%106.35M	-25.62%121M	-22.86%132.01M
Non current assets
Net PPE	-63.37%648K	-57.99%733K	-57.99%733K	7.57%1.54M	7.97%1.64M	9.26%1.77M	723.11%1.75M	723.11%1.75M	613.50%1.43M	1,687.06%1.52M
-Gross PPE	-63.37%648K	-53.82%853K	-53.82%853K	7.57%1.54M	7.97%1.64M	9.26%1.77M	435.36%1.85M	435.36%1.85M	351.58%1.43M	707.98%1.52M
-Accumulated depreciation	----	-17.65%-120K	-17.65%-120K	----	----	----	23.31%-102K	23.31%-102K	----	----
Other non current assets	-20.99%64K	-3.57%81K	-3.57%81K	2.53%81K	1.28%79K	3.85%81K	7.69%84K	7.69%84K	1.28%79K	0.00%78K
Total non current assets	-61.51%712K	-55.49%814K	-55.49%814K	7.30%1.62M	7.64%1.72M	9.02%1.85M	530.69%1.83M	530.69%1.83M	441.73%1.51M	879.75%1.6M
Total assets	-14.39%84.64M	-0.69%107.44M	-0.69%107.44M	6.44%130.39M	10.80%148.04M	-31.54%98.87M	-29.76%108.18M	-29.76%108.18M	-24.82%122.5M	-22.01%133.61M
Liabilities
Current liabilities
Payables	-62.49%676K	360.49%8.72M	360.49%8.72M	12.97%2.47M	17.18%1.83M	15.07%1.8M	-6.38%1.89M	-6.38%1.89M	72.23%2.19M	259.45%1.56M
-accounts payable	-62.49%676K	360.49%8.72M	360.49%8.72M	12.97%2.47M	17.18%1.83M	15.07%1.8M	-6.38%1.89M	-6.38%1.89M	72.23%2.19M	259.45%1.56M
Current accrued expenses	-90.30%637K	28.88%5.18M	28.88%5.18M	51.95%6.94M	97.58%9.07M	40.63%6.57M	27.50%4.02M	27.50%4.02M	22.82%4.56M	118.73%4.59M
Current debt and capital lease obligation	-8.82%331K	-18.07%331K	-18.07%331K	-20.73%325K	-22.06%318K	-20.57%363K	--404K	--404K	--410K	--408K
-Current capital lease obligation	-8.82%331K	-18.07%331K	-18.07%331K	-20.73%325K	-22.06%318K	-20.57%363K	--404K	--404K	--410K	--408K
Current liabilities	-73.15%2.81M	155.15%18.18M	155.15%18.18M	43.52%13.56M	64.82%13.74M	32.50%10.48M	14.87%7.12M	14.87%7.12M	48.75%9.45M	149.85%8.34M
Non current liabilities
Long term debt and capital lease obligation	-41.16%576K	-39.38%642K	-39.38%642K	-13.89%812K	-15.46%897K	-13.13%979K	--1.06M	--1.06M	--943K	--1.06M
-Long term capital lease obligation	-41.16%576K	-39.38%642K	-39.38%642K	-13.89%812K	-15.46%897K	-13.13%979K	--1.06M	--1.06M	--943K	--1.06M
Employee benefits	-97.84%7K	-75.86%7K	-75.86%7K	1,519.70%1.07M	1,492.73%876K	468.42%324K	-93.47%29K	-93.47%29K	-76.76%66K	-84.85%55K
Total non current liabilities	-55.26%583K	-40.35%649K	-40.35%649K	86.42%1.88M	58.87%1.77M	10.05%1.3M	78.07%1.09M	78.07%1.09M	164.14%1.01M	167.63%1.12M
Total liabilities	-71.17%3.4M	129.25%18.83M	129.25%18.83M	47.66%15.44M	64.12%15.51M	29.58%11.78M	20.53%8.21M	20.53%8.21M	55.29%10.46M	151.83%9.45M
Shareholders'equity
Share capital	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K
-common stock	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K	0.00%3K
Retained earnings	-49.48%-226.9M	-59.84%-218.47M	-59.84%-218.47M	-54.79%-190.52M	-55.64%-171.32M	-55.26%-151.79M	-61.32%-136.68M	-61.32%-136.68M	-66.06%-123.08M	-79.32%-110.08M
Paid-in capital	29.01%308.15M	29.73%307.07M	29.73%307.07M	29.91%305.48M	29.83%303.88M	2.51%238.86M	2.07%236.69M	2.07%236.69M	2.10%235.15M	2.24%234.06M
Gains losses not affecting retained earnings	-200.00%-12K	118.60%8K	118.60%8K	19.23%-21K	-118.45%-31K	-81.25%12K	-226.47%-43K	-226.47%-43K	-252.94%-26K	3,260.00%168K
Total stockholders'equity	-6.71%81.24M	-11.36%88.61M	-11.36%88.61M	2.59%114.94M	6.74%132.53M	-35.64%87.08M	-32.09%99.97M	-32.09%99.97M	-28.27%112.05M	-25.90%124.16M
Total equity	-6.71%81.24M	-11.36%88.61M	-11.36%88.61M	2.59%114.94M	6.74%132.53M	-35.64%87.08M	-32.09%99.97M	-32.09%99.97M	-28.27%112.05M	-25.90%124.16M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall